4D-110

4D Molecular Therapeutics · Phase 1 active Biologic

At a glance

Generic name	4D-110
Sponsor	4D Molecular Therapeutics
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

4D-110 CI brief — competitive landscape report
4D-110 updates RSS · CI watch RSS
4D Molecular Therapeutics portfolio CI